{"schema_version":"secwatch.filing_event.v1","accession":"0001757898-22-000020","form_type":"8-K","ticker":"STE","cik":"0001757898","company_name":"STERIS plc","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.001829+00:00","generated_at":"2026-06-22T01:40:35.477859+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"STERIS reports flat Q2 revenue, adjusted EPS $1.99, $490.6M dental impairment","bullets":["Revenue flat at $1.2B; constant currency organic revenue grew 7% YoY.","GAAP loss per share ($3.15) due to $490.6M dental impairment; adjusted EPS $1.99.","Dental segment impairment charge of $490.6M recorded in the quarter.","Fiscal 2023 second quarter ended September 30, 2022 results announced November 9, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001757898-22-000020","json":"https://secwatch.observer/filing/0001757898-22-000020.json","markdown":"https://secwatch.observer/filing/0001757898-22-000020.md","text":"https://secwatch.observer/filing/0001757898-22-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757898/000175789822000020/0001757898-22-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757898/000175789822000020/ste-20221109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T01:40:35.477859+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cd1143537f3f857528e7417bc7421d2c7f1e1bf8","claim":"STERIS plc reported fiscal 2023 second quarter ended September 30, 2022 results: revenue $1.2 billion, EPS as reported loss per share of ($3.15); adjusted EPS of $1.99.","evidence_excerpt":"STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 second quarter ended September 30, 2022. Revenue as reported for the quarter was flat at $1.2 billion compared with $1.2 billion in the second quarter of fiscal 2022. Constant currency organic revenue (see","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1757898/000175789822000020/0001757898-22-000020-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal 2023 second quarter ended September 30, 2022"},{"label":"Revenue","value":"$1.2 billion"},{"label":"EPS","value":"as reported loss per share of ($3.15); adjusted EPS of $1.99"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}